Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction

Luc Rochette, Eve Rigal, Geoffrey Dogon, Gabriel Malka, Marianne Zeller, Catherine Vergely, Yves Cottin

Open source

DOI
10.1016/j.acvd.2021.10.013
Published
2022-01
Container
Archives of Cardiovascular Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.acvd.2021.10.013,
  title = {Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction},
  author = {Luc Rochette and Eve Rigal and Geoffrey Dogon and Gabriel Malka and Marianne Zeller and Catherine Vergely and Yves Cottin},
  year = {2022},
  journal = {Archives of Cardiovascular Diseases},
  doi = {10.1016/j.acvd.2021.10.013},
  url = {https://doi.org/10.1016/j.acvd.2021.10.013}
}

RIS

TY  - JOUR
TI  - Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction
AU  - Luc Rochette
AU  - Eve Rigal
AU  - Geoffrey Dogon
AU  - Gabriel Malka
AU  - Marianne Zeller
AU  - Catherine Vergely
AU  - Yves Cottin
PY  - 2022
JO  - Archives of Cardiovascular Diseases
DO  - 10.1016/j.acvd.2021.10.013
UR  - https://doi.org/10.1016/j.acvd.2021.10.013
ER  - 

APA

Rochette, L., Rigal, E., Dogon, G., Malka, G., Zeller, M., Vergely, C., & Cottin, Y. (2022). Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2021.10.013

Source records